References
- Horsman M R, Chaplin D J, Brown J M. Radiosensitization by nicotinamide in vivo: A greater enhancement of tumor dam-age compared to that of normal tissues. Radiat Res 1987; 109: 479–89
- Lee I, Song C W. The oxygenation of murine tumor isografts and human tumor xenografts by nicotinamide. Radiat Res 1992; 130: 65–71
- Ono K, Masunaga S, Akuta K, Akaboshi M, Abe M. Ra-diosensitization of SCCVII tumours and normal tissues by nicotinamide and carbogen: analysis by micronucleus assay. Radiother Oncol 1993; 28: 162–7
- Chaplin D J, Horsman M R, Trotter M J. Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumor. J Natl Cancer Inst 1990; 82: 672–6
- Lee I, Kim J H, Levitt S H, Song C W. Increases in tumor response by pentoxifylline alone or in combination with nicotinamide. Int J Radiat Oncol Biol Phys 1992; 22: 425–9
- Song C W, Hasegawa T, Kwon H C, Lyons J C, Levitt S H. Increase in tumor oxygenation and radiosensitivity caused by pentoxifylline. Radiat Res 1992; 130: 205–10
- Honess D J, Dennis I F, Bleehen N M. Pentoxifylline: its phar-macokinetics and ability to improve tumour perfusion and radiosensitivity in mice. Radiother Oncol 1993; 28: 208–18
- Honess D J, Bleehen N M. Effects of the radiosensitising agent nicotinamide on relative tissue perfusion and kidney function in C3H mice. Radiother Oncol 1993; 27: 140–8
- Horsman M R, Brown J M, Hirst V K, et al. Mechanism of action of the selective tumor radiosensitizer nicotinamide. Int J Radiat Oncol Biol Phys 1988; 15: 685–90
- Kelleher D K, Vaupel P W. Nicotinamide exerts different acute effects on microcirculatory function and tissue oxygenation in rat tumors. Int J Radiat Oncol Biol Phys 1993; 26: 95–102
- Horsman M R, Nordsmark M, Khalil A, Chaplin D J, Overgaard J. Tumour radiosensitization by nicotinamide: Is it the result of an improvement in tumour oxygenation?. Adv Exp Med Biol 1994; 345: 403–9
- Ward A, Clissold S P. Pentoxifylline. A review of its pharma-codynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987; 34: 50–97
- Novick W J, Sullivan G, Mandell G L. Newer pharmacological effects of pentoxifylline. Biorheology 1990; 24: 449–54
- Currie M S, Simel D L, Christenson R H, et al. Anti-inflammatory effects of pentoxifylline in claudication. Am J Med Sci 1991; 301: 85–90
- Teicher B A, Sotomayor E A, Robinson M F, Dupuis N P, Schwartz G N, Frei E. Tumor oxygenation and radiosensitization by pentoxifylline and a perflubron emulsion/carbogen breathing. Int J Oncol 1993; 2: 13–21
- Horsman M R. Carbogen and nicotinamide: Expectations too high? (Response to J. Martin Brown). Radiother Oncol 1992; 24: 121–2
- Horsman M R, Hoyer M, Honess D J, Dennis I F, Overgaard J. Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy. Radiother Oncol 1993; 27: 131–9
- Song C W, Makepeace C M, Griffin R J, et al. Increase in tumor blood flow by pentoxifylline. Int J Radiat Oncol Biol Phys 1994; 29: 433–7
- Kelleher D K, Vaupel P W. Possible mehcanisms involved in tumor radiosensitization following nicotinamide administration. Radiother Oncol 1994; 32: 47–53
- Lee I, Boucher Y, Jain R K. Nicotinamide can lower tumor interstitial fluid pressure: Mechanistic and therapeutic implications. Cancer Res 1992; 52: 3237–40